Shares of Nanosonics Limited (OTCMKTS:NNCSF – Get Free Report) traded up 7.1% during trading on Tuesday. The stock traded as high as $2.01 and last traded at $1.97. Approximately 325 shares changed hands during trading, a decline of 87% from the average session volume of 2,443 shares. The stock had previously closed at $1.84.
Wall Street Analyst Weigh In
Separately, Royal Bank Of Canada upgraded shares of Nanosonics from a “sector perform” rating to an “outperform” rating in a research note on Tuesday, September 15th. One analyst has rated the stock with a Buy rating. Based on data from MarketBeat.com, Nanosonics currently has a consensus rating of “Buy”.
Check Out Our Latest Stock Report on NNCSF
Nanosonics Stock Performance
The firm’s fifty day moving average price is $1.93 and its two-hundred day moving average price is $2.31.
Nanosonics Company Profile
Nanosonics Limited is an Australian medical technology company focused on infection prevention and the development of automated disinfection solutions for healthcare environments. The company is best known for its trophon platform, which is designed to provide high-level disinfection for ultrasound transducers that come into contact with patients.
Its product portfolio includes the trophon2 system, related disinfectant consumables and accessories, and software and workflow tools such as Nanosonics AuditPro.
Recommended Stories
- Five stocks we like better than Nanosonics
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Nanosonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosonics and related companies with MarketBeat.com's FREE daily email newsletter.
